nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—Corticosteroid Hormone Receptor Agonists—Fluocinolone Acetonide—psoriasis	0.0529	0.223	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Fluocinonide—psoriasis	0.0529	0.223	CiPCiCtD
Betamethasone—Clobetasol propionate—psoriasis	0.0371	0.194	CrCtD
Betamethasone—psoriatic arthritis—psoriasis	0.0367	0.234	CtDrD
Betamethasone—atopic dermatitis—psoriasis	0.0336	0.214	CtDrD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Hydrocortisone—psoriasis	0.0304	0.128	CiPCiCtD
Betamethasone—brain cancer—Triamcinolone—psoriasis	0.0303	0.245	CpDpCtD
Betamethasone—ankylosing spondylitis—psoriasis	0.0302	0.193	CtDrD
Betamethasone—Beclomethasone—psoriasis	0.0297	0.155	CrCtD
Betamethasone—Fluocinonide—psoriasis	0.0297	0.155	CrCtD
Betamethasone—Fluocinolone Acetonide—psoriasis	0.0289	0.151	CrCtD
Betamethasone—systemic lupus erythematosus—psoriasis	0.0288	0.184	CtDrD
Betamethasone—rheumatoid arthritis—psoriasis	0.0272	0.174	CtDrD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—psoriasis	0.0267	0.113	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—psoriasis	0.0258	0.109	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Prednisolone—psoriasis	0.025	0.105	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Prednisone—psoriasis	0.0236	0.0995	CiPCiCtD
Betamethasone—kidney cancer—Hydrocortisone—psoriasis	0.0195	0.158	CpDpCtD
Betamethasone—colon cancer—Dexamethasone—psoriasis	0.0165	0.133	CpDpCtD
Betamethasone—brain cancer—Dexamethasone—psoriasis	0.0165	0.133	CpDpCtD
Betamethasone—Hydrocortisone—psoriasis	0.0146	0.0761	CrCtD
Betamethasone—prostate cancer—Hydrocortisone—psoriasis	0.0141	0.114	CpDpCtD
Betamethasone—Dexamethasone—psoriasis	0.0136	0.0707	CrCtD
Betamethasone—Triamcinolone—psoriasis	0.0132	0.0691	CrCtD
Betamethasone—PLA2G1B—Dexamethasone—psoriasis	0.013	0.123	CbGbCtD
Betamethasone—NR3C1—Clobetasol propionate—psoriasis	0.0127	0.12	CbGbCtD
Betamethasone—Prednisone—psoriasis	0.0126	0.0656	CrCtD
Betamethasone—Prednisolone—psoriasis	0.0123	0.064	CrCtD
Betamethasone—kidney cancer—Dexamethasone—psoriasis	0.0119	0.0965	CpDpCtD
Betamethasone—NR3C2—Prednisolone—psoriasis	0.00981	0.0931	CbGbCtD
Betamethasone—NR3C1—Fluocinonide—psoriasis	0.0096	0.0911	CbGbCtD
Betamethasone—NR3C1—Beclomethasone—psoriasis	0.0096	0.0911	CbGbCtD
Betamethasone—NR3C1—Fluocinolone Acetonide—psoriasis	0.0096	0.0911	CbGbCtD
Betamethasone—prostate cancer—Dexamethasone—psoriasis	0.0086	0.0698	CpDpCtD
Betamethasone—breast cancer—Dexamethasone—psoriasis	0.00604	0.049	CpDpCtD
Betamethasone—NR3C2—Dexamethasone—psoriasis	0.00578	0.0549	CbGbCtD
Betamethasone—NR3C1—Triamcinolone—psoriasis	0.00382	0.0363	CbGbCtD
Betamethasone—PGR—Dexamethasone—psoriasis	0.00373	0.0355	CbGbCtD
Betamethasone—NR3C1—Prednisolone—psoriasis	0.00323	0.0307	CbGbCtD
Betamethasone—NR3C1—Hydrocortisone—psoriasis	0.00307	0.0291	CbGbCtD
Betamethasone—NR3C1—Prednisone—psoriasis	0.00305	0.029	CbGbCtD
Betamethasone—PTGS2—Triamcinolone—psoriasis	0.0027	0.0256	CbGbCtD
Betamethasone—CYP19A1—Dexamethasone—psoriasis	0.0021	0.0199	CbGbCtD
Betamethasone—NR3C1—Dexamethasone—psoriasis	0.00191	0.0181	CbGbCtD
Betamethasone—PTGS2—Dexamethasone—psoriasis	0.00135	0.0128	CbGbCtD
Betamethasone—Fluticasone furoate—Clobetasol propionate—psoriasis	0.00131	0.00954	CrCrCtD
Betamethasone—CYP3A4—Calcitriol—psoriasis	0.00119	0.0113	CbGbCtD
Betamethasone—Flumethasone Pivalate—Clobetasol propionate—psoriasis	0.00118	0.00857	CrCrCtD
Betamethasone—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.00114	0.0083	CrCrCtD
Betamethasone—Difluprednate—Clobetasol propionate—psoriasis	0.00114	0.0083	CrCrCtD
Betamethasone—Halobetasol Propionate—Clobetasol propionate—psoriasis	0.00114	0.0083	CrCrCtD
Betamethasone—Prednicarbate—Clobetasol propionate—psoriasis	0.00107	0.0078	CrCrCtD
Betamethasone—Beclomethasone—Clobetasol propionate—psoriasis	0.00107	0.0078	CrCrCtD
Betamethasone—Clocortolone—Clobetasol propionate—psoriasis	0.00107	0.0078	CrCrCtD
Betamethasone—Fluocinonide—Clobetasol propionate—psoriasis	0.00107	0.0078	CrCrCtD
Betamethasone—Fluticasone furoate—Fluocinonide—psoriasis	0.00105	0.00764	CrCrCtD
Betamethasone—Fluticasone furoate—Beclomethasone—psoriasis	0.00105	0.00764	CrCrCtD
Betamethasone—Fluticasone furoate—Fluocinolone Acetonide—psoriasis	0.00102	0.00743	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Clobetasol propionate—psoriasis	0.00101	0.00737	CrCrCtD
Betamethasone—Alclometasone—Clobetasol propionate—psoriasis	0.00101	0.00737	CrCrCtD
Betamethasone—Amcinonide—Clobetasol propionate—psoriasis	0.000987	0.00717	CrCrCtD
Betamethasone—Fluoxymesterone—Clobetasol propionate—psoriasis	0.000987	0.00717	CrCrCtD
Betamethasone—Budesonide—Clobetasol propionate—psoriasis	0.000987	0.00717	CrCrCtD
Betamethasone—Flurandrenolide—Fluocinonide—psoriasis	0.000978	0.0071	CrCrCtD
Betamethasone—Desonide—Clobetasol propionate—psoriasis	0.000961	0.00699	CrCrCtD
Betamethasone—Diflorasone—Clobetasol propionate—psoriasis	0.000961	0.00699	CrCrCtD
Betamethasone—Fludrocortisone—Clobetasol propionate—psoriasis	0.000961	0.00699	CrCrCtD
Betamethasone—Prednisone—Clobetasol propionate—psoriasis	0.000961	0.00699	CrCrCtD
Betamethasone—Flurandrenolide—Fluocinolone Acetonide—psoriasis	0.00095	0.0069	CrCrCtD
Betamethasone—Flumethasone Pivalate—Fluocinonide—psoriasis	0.000945	0.00687	CrCrCtD
Betamethasone—Flumethasone Pivalate—Beclomethasone—psoriasis	0.000945	0.00687	CrCrCtD
Betamethasone—Paramethasone—Clobetasol propionate—psoriasis	0.000937	0.00681	CrCrCtD
Betamethasone—CYP3A4—Methoxsalen—psoriasis	0.000928	0.00881	CbGbCtD
Betamethasone—Flumethasone Pivalate—Fluocinolone Acetonide—psoriasis	0.000918	0.00667	CrCrCtD
Betamethasone—Halobetasol Propionate—Beclomethasone—psoriasis	0.000914	0.00665	CrCrCtD
Betamethasone—Difluprednate—Fluocinonide—psoriasis	0.000914	0.00665	CrCrCtD
Betamethasone—Fluticasone Propionate—Beclomethasone—psoriasis	0.000914	0.00665	CrCrCtD
Betamethasone—Difluprednate—Beclomethasone—psoriasis	0.000914	0.00665	CrCrCtD
Betamethasone—Halobetasol Propionate—Fluocinonide—psoriasis	0.000914	0.00665	CrCrCtD
Betamethasone—Fluticasone Propionate—Fluocinonide—psoriasis	0.000914	0.00665	CrCrCtD
Betamethasone—Desoximetasone—Clobetasol propionate—psoriasis	0.000914	0.00665	CrCrCtD
Betamethasone—Mometasone—Clobetasol propionate—psoriasis	0.000893	0.00649	CrCrCtD
Betamethasone—Loteprednol—Clobetasol propionate—psoriasis	0.000893	0.00649	CrCrCtD
Betamethasone—Fluprednidene Acetate—Clobetasol propionate—psoriasis	0.000893	0.00649	CrCrCtD
Betamethasone—Fluorometholone—Clobetasol propionate—psoriasis	0.000893	0.00649	CrCrCtD
Betamethasone—Triamcinolone—Clobetasol propionate—psoriasis	0.000893	0.00649	CrCrCtD
Betamethasone—ABCB1—Mycophenolate mofetil—psoriasis	0.00089	0.00845	CbGbCtD
Betamethasone—Halobetasol Propionate—Fluocinolone Acetonide—psoriasis	0.000889	0.00646	CrCrCtD
Betamethasone—Difluprednate—Fluocinolone Acetonide—psoriasis	0.000889	0.00646	CrCrCtD
Betamethasone—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000889	0.00646	CrCrCtD
Betamethasone—Rimexolone—Clobetasol propionate—psoriasis	0.000872	0.00634	CrCrCtD
Betamethasone—Dexamethasone—Clobetasol propionate—psoriasis	0.000872	0.00634	CrCrCtD
Betamethasone—Fluocinonide—Beclomethasone—psoriasis	0.00086	0.00625	CrCrCtD
Betamethasone—Clocortolone—Beclomethasone—psoriasis	0.00086	0.00625	CrCrCtD
Betamethasone—Beclomethasone—Fluocinonide—psoriasis	0.00086	0.00625	CrCrCtD
Betamethasone—Prednicarbate—Beclomethasone—psoriasis	0.00086	0.00625	CrCrCtD
Betamethasone—Clocortolone—Fluocinonide—psoriasis	0.00086	0.00625	CrCrCtD
Betamethasone—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000836	0.00607	CrCrCtD
Betamethasone—Beclomethasone—Fluocinolone Acetonide—psoriasis	0.000836	0.00607	CrCrCtD
Betamethasone—Clocortolone—Fluocinolone Acetonide—psoriasis	0.000836	0.00607	CrCrCtD
Betamethasone—Fluocortolone—Fluocinonide—psoriasis	0.000835	0.00607	CrCrCtD
Betamethasone—Methylprednisolone—Clobetasol propionate—psoriasis	0.000834	0.00606	CrCrCtD
Betamethasone—Prednisolone—Clobetasol propionate—psoriasis	0.000817	0.00594	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Fluocinonide—psoriasis	0.000812	0.0059	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Beclomethasone—psoriasis	0.000812	0.0059	CrCrCtD
Betamethasone—Alclometasone—Beclomethasone—psoriasis	0.000812	0.0059	CrCrCtD
Betamethasone—Fluocortolone—Fluocinolone Acetonide—psoriasis	0.000812	0.0059	CrCrCtD
Betamethasone—Budesonide—Fluocinonide—psoriasis	0.00079	0.00574	CrCrCtD
Betamethasone—Amcinonide—Fluocinonide—psoriasis	0.00079	0.00574	CrCrCtD
Betamethasone—Amcinonide—Beclomethasone—psoriasis	0.00079	0.00574	CrCrCtD
Betamethasone—Budesonide—Beclomethasone—psoriasis	0.00079	0.00574	CrCrCtD
Betamethasone—Alclometasone—Fluocinolone Acetonide—psoriasis	0.000789	0.00574	CrCrCtD
Betamethasone—Desonide—Fluocinonide—psoriasis	0.00077	0.0056	CrCrCtD
Betamethasone—Clobetasol propionate—Fluocinonide—psoriasis	0.00077	0.0056	CrCrCtD
Betamethasone—Desonide—Beclomethasone—psoriasis	0.00077	0.0056	CrCrCtD
Betamethasone—Diflorasone—Fluocinonide—psoriasis	0.00077	0.0056	CrCrCtD
Betamethasone—Diflorasone—Beclomethasone—psoriasis	0.00077	0.0056	CrCrCtD
Betamethasone—Flunisolide—Fluocinonide—psoriasis	0.00077	0.0056	CrCrCtD
Betamethasone—Clobetasol propionate—Beclomethasone—psoriasis	0.00077	0.0056	CrCrCtD
Betamethasone—Budesonide—Fluocinolone Acetonide—psoriasis	0.000768	0.00558	CrCrCtD
Betamethasone—Amcinonide—Fluocinolone Acetonide—psoriasis	0.000768	0.00558	CrCrCtD
Betamethasone—ABCB1—Prednisolone—psoriasis	0.000753	0.00715	CbGbCtD
Betamethasone—Paramethasone—Fluocinonide—psoriasis	0.000751	0.00546	CrCrCtD
Betamethasone—Diflorasone—Fluocinolone Acetonide—psoriasis	0.000748	0.00544	CrCrCtD
Betamethasone—Fludrocortisone—Fluocinolone Acetonide—psoriasis	0.000748	0.00544	CrCrCtD
Betamethasone—Desonide—Fluocinolone Acetonide—psoriasis	0.000748	0.00544	CrCrCtD
Betamethasone—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	0.000748	0.00544	CrCrCtD
Betamethasone—Flunisolide—Fluocinolone Acetonide—psoriasis	0.000748	0.00544	CrCrCtD
Betamethasone—Desoximetasone—Beclomethasone—psoriasis	0.000732	0.00532	CrCrCtD
Betamethasone—Desoximetasone—Fluocinonide—psoriasis	0.000732	0.00532	CrCrCtD
Betamethasone—Paramethasone—Fluocinolone Acetonide—psoriasis	0.000729	0.0053	CrCrCtD
Betamethasone—Fluorometholone—Fluocinonide—psoriasis	0.000715	0.0052	CrCrCtD
Betamethasone—Loteprednol—Beclomethasone—psoriasis	0.000715	0.0052	CrCrCtD
Betamethasone—Triamcinolone—Fluocinonide—psoriasis	0.000715	0.0052	CrCrCtD
Betamethasone—Mometasone—Fluocinonide—psoriasis	0.000715	0.0052	CrCrCtD
Betamethasone—Triamcinolone—Beclomethasone—psoriasis	0.000715	0.0052	CrCrCtD
Betamethasone—Mometasone—Beclomethasone—psoriasis	0.000715	0.0052	CrCrCtD
Betamethasone—Fluprednidene Acetate—Fluocinonide—psoriasis	0.000715	0.0052	CrCrCtD
Betamethasone—Fluorometholone—Beclomethasone—psoriasis	0.000715	0.0052	CrCrCtD
Betamethasone—Fluprednidene Acetate—Beclomethasone—psoriasis	0.000715	0.0052	CrCrCtD
Betamethasone—ABCB1—Hydrocortisone—psoriasis	0.000714	0.00678	CbGbCtD
Betamethasone—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.000712	0.00517	CrCrCtD
Betamethasone—ABCB1—Prednisone—psoriasis	0.000711	0.00675	CbGbCtD
Betamethasone—Rimexolone—Beclomethasone—psoriasis	0.000699	0.00508	CrCrCtD
Betamethasone—Rimexolone—Fluocinonide—psoriasis	0.000699	0.00508	CrCrCtD
Betamethasone—Dexamethasone—Fluocinonide—psoriasis	0.000699	0.00508	CrCrCtD
Betamethasone—Dexamethasone—Beclomethasone—psoriasis	0.000699	0.00508	CrCrCtD
Betamethasone—Triamcinolone—Fluocinolone Acetonide—psoriasis	0.000695	0.00505	CrCrCtD
Betamethasone—Fluorometholone—Fluocinolone Acetonide—psoriasis	0.000695	0.00505	CrCrCtD
Betamethasone—Fluprednidene Acetate—Fluocinolone Acetonide—psoriasis	0.000695	0.00505	CrCrCtD
Betamethasone—Mometasone—Fluocinolone Acetonide—psoriasis	0.000695	0.00505	CrCrCtD
Betamethasone—Rimexolone—Fluocinolone Acetonide—psoriasis	0.000679	0.00493	CrCrCtD
Betamethasone—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.000679	0.00493	CrCrCtD
Betamethasone—ABCB1—Cyclosporine—psoriasis	0.000674	0.0064	CbGbCtD
Betamethasone—Methylprednisolone—Fluocinonide—psoriasis	0.000668	0.00486	CrCrCtD
Betamethasone—Prednisolone—Beclomethasone—psoriasis	0.000654	0.00475	CrCrCtD
Betamethasone—Methylprednisolone—Fluocinolone Acetonide—psoriasis	0.000649	0.00472	CrCrCtD
Betamethasone—Prednisolone—Fluocinolone Acetonide—psoriasis	0.000636	0.00462	CrCrCtD
Betamethasone—CYP3A4—Cholecalciferol—psoriasis	0.000615	0.00584	CbGbCtD
Betamethasone—CYP3A4—Mycophenolate mofetil—psoriasis	0.000533	0.00506	CbGbCtD
Betamethasone—CYP3A4—Triamcinolone—psoriasis	0.000533	0.00506	CbGbCtD
Betamethasone—Flurandrenolide—Hydrocortisone—psoriasis	0.00048	0.00349	CrCrCtD
Betamethasone—Fluticasone furoate—Dexamethasone—psoriasis	0.000479	0.00348	CrCrCtD
Betamethasone—Fluticasone furoate—Triamcinolone—psoriasis	0.000468	0.0034	CrCrCtD
Betamethasone—CYP3A4—Prednisolone—psoriasis	0.000451	0.00429	CbGbCtD
Betamethasone—Flurandrenolide—Dexamethasone—psoriasis	0.000446	0.00324	CrCrCtD
Betamethasone—ABCB1—Dexamethasone—psoriasis	0.000444	0.00422	CbGbCtD
Betamethasone—Flumethasone Pivalate—Dexamethasone—psoriasis	0.000431	0.00313	CrCrCtD
Betamethasone—CYP3A4—Hydrocortisone—psoriasis	0.000428	0.00406	CbGbCtD
Betamethasone—CYP3A4—Prednisone—psoriasis	0.000426	0.00405	CbGbCtD
Betamethasone—Prednicarbate—Hydrocortisone—psoriasis	0.000422	0.00307	CrCrCtD
Betamethasone—Flumethasone Pivalate—Triamcinolone—psoriasis	0.000421	0.00306	CrCrCtD
Betamethasone—Difluprednate—Dexamethasone—psoriasis	0.000417	0.00303	CrCrCtD
Betamethasone—Fluticasone Propionate—Dexamethasone—psoriasis	0.000417	0.00303	CrCrCtD
Betamethasone—Halobetasol Propionate—Dexamethasone—psoriasis	0.000417	0.00303	CrCrCtD
Betamethasone—Fluticasone Propionate—Triamcinolone—psoriasis	0.000407	0.00296	CrCrCtD
Betamethasone—Halobetasol Propionate—Triamcinolone—psoriasis	0.000407	0.00296	CrCrCtD
Betamethasone—Difluprednate—Triamcinolone—psoriasis	0.000407	0.00296	CrCrCtD
Betamethasone—CYP3A4—Cyclosporine—psoriasis	0.000404	0.00384	CbGbCtD
Betamethasone—Flurandrenolide—Prednisolone—psoriasis	0.000403	0.00293	CrCrCtD
Betamethasone—Alclometasone—Hydrocortisone—psoriasis	0.000399	0.0029	CrCrCtD
Betamethasone—Prednicarbate—Dexamethasone—psoriasis	0.000392	0.00285	CrCrCtD
Betamethasone—Testolactone—Dexamethasone—psoriasis	0.000392	0.00285	CrCrCtD
Betamethasone—Clocortolone—Dexamethasone—psoriasis	0.000392	0.00285	CrCrCtD
Betamethasone—Fluocinonide—Dexamethasone—psoriasis	0.000392	0.00285	CrCrCtD
Betamethasone—Beclomethasone—Dexamethasone—psoriasis	0.000392	0.00285	CrCrCtD
Betamethasone—Budesonide—Hydrocortisone—psoriasis	0.000388	0.00282	CrCrCtD
Betamethasone—Fluoxymesterone—Hydrocortisone—psoriasis	0.000388	0.00282	CrCrCtD
Betamethasone—Fluocinonide—Triamcinolone—psoriasis	0.000383	0.00278	CrCrCtD
Betamethasone—Testolactone—Triamcinolone—psoriasis	0.000383	0.00278	CrCrCtD
Betamethasone—Clocortolone—Triamcinolone—psoriasis	0.000383	0.00278	CrCrCtD
Betamethasone—Beclomethasone—Triamcinolone—psoriasis	0.000383	0.00278	CrCrCtD
Betamethasone—Prednicarbate—Triamcinolone—psoriasis	0.000383	0.00278	CrCrCtD
Betamethasone—Fluocortolone—Dexamethasone—psoriasis	0.000381	0.00277	CrCrCtD
Betamethasone—Desonide—Hydrocortisone—psoriasis	0.000378	0.00275	CrCrCtD
Betamethasone—Flunisolide—Hydrocortisone—psoriasis	0.000378	0.00275	CrCrCtD
Betamethasone—Prednisone—Hydrocortisone—psoriasis	0.000378	0.00275	CrCrCtD
Betamethasone—Fludrocortisone—Hydrocortisone—psoriasis	0.000378	0.00275	CrCrCtD
Betamethasone—Fluocortolone—Triamcinolone—psoriasis	0.000372	0.0027	CrCrCtD
Betamethasone—Alclometasone—Dexamethasone—psoriasis	0.00037	0.00269	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Dexamethasone—psoriasis	0.00037	0.00269	CrCrCtD
Betamethasone—Paramethasone—Hydrocortisone—psoriasis	0.000368	0.00268	CrCrCtD
Betamethasone—Prednicarbate—Prednisone—psoriasis	0.000363	0.00264	CrCrCtD
Betamethasone—Testolactone—Prednisone—psoriasis	0.000363	0.00264	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Triamcinolone—psoriasis	0.000362	0.00263	CrCrCtD
Betamethasone—Alclometasone—Triamcinolone—psoriasis	0.000362	0.00263	CrCrCtD
Betamethasone—Fluoxymesterone—Dexamethasone—psoriasis	0.00036	0.00262	CrCrCtD
Betamethasone—Budesonide—Dexamethasone—psoriasis	0.00036	0.00262	CrCrCtD
Betamethasone—Amcinonide—Dexamethasone—psoriasis	0.00036	0.00262	CrCrCtD
Betamethasone—Desoximetasone—Hydrocortisone—psoriasis	0.000359	0.00261	CrCrCtD
Betamethasone—ABCB1—Methotrexate—psoriasis	0.000357	0.00339	CbGbCtD
Betamethasone—Beclomethasone—Prednisolone—psoriasis	0.000355	0.00258	CrCrCtD
Betamethasone—Clocortolone—Prednisolone—psoriasis	0.000355	0.00258	CrCrCtD
Betamethasone—Prednicarbate—Prednisolone—psoriasis	0.000355	0.00258	CrCrCtD
Betamethasone—Testolactone—Prednisolone—psoriasis	0.000355	0.00258	CrCrCtD
Betamethasone—Fluocortolone—Prednisone—psoriasis	0.000353	0.00257	CrCrCtD
Betamethasone—Budesonide—Triamcinolone—psoriasis	0.000352	0.00256	CrCrCtD
Betamethasone—Fluoxymesterone—Triamcinolone—psoriasis	0.000352	0.00256	CrCrCtD
Betamethasone—Amcinonide—Triamcinolone—psoriasis	0.000352	0.00256	CrCrCtD
Betamethasone—Fluorometholone—Hydrocortisone—psoriasis	0.000351	0.00255	CrCrCtD
Betamethasone—Loteprednol—Hydrocortisone—psoriasis	0.000351	0.00255	CrCrCtD
Betamethasone—Fluprednidene Acetate—Hydrocortisone—psoriasis	0.000351	0.00255	CrCrCtD
Betamethasone—Mometasone—Hydrocortisone—psoriasis	0.000351	0.00255	CrCrCtD
Betamethasone—Triamcinolone—Hydrocortisone—psoriasis	0.000351	0.00255	CrCrCtD
Betamethasone—Flunisolide—Dexamethasone—psoriasis	0.000351	0.00255	CrCrCtD
Betamethasone—Clobetasol propionate—Dexamethasone—psoriasis	0.000351	0.00255	CrCrCtD
Betamethasone—Desonide—Dexamethasone—psoriasis	0.000351	0.00255	CrCrCtD
Betamethasone—Prednisone—Dexamethasone—psoriasis	0.000351	0.00255	CrCrCtD
Betamethasone—Diflorasone—Dexamethasone—psoriasis	0.000351	0.00255	CrCrCtD
Betamethasone—Fludrocortisone—Dexamethasone—psoriasis	0.000351	0.00255	CrCrCtD
Betamethasone—Fluocortolone—Prednisolone—psoriasis	0.000345	0.0025	CrCrCtD
Betamethasone—Alclometasone—Prednisone—psoriasis	0.000343	0.00249	CrCrCtD
Betamethasone—Rimexolone—Hydrocortisone—psoriasis	0.000343	0.00249	CrCrCtD
Betamethasone—Dexamethasone—Hydrocortisone—psoriasis	0.000343	0.00249	CrCrCtD
Betamethasone—Desonide—Triamcinolone—psoriasis	0.000343	0.00249	CrCrCtD
Betamethasone—Prednisone—Triamcinolone—psoriasis	0.000343	0.00249	CrCrCtD
Betamethasone—Diflorasone—Triamcinolone—psoriasis	0.000343	0.00249	CrCrCtD
Betamethasone—Flunisolide—Triamcinolone—psoriasis	0.000343	0.00249	CrCrCtD
Betamethasone—Fludrocortisone—Triamcinolone—psoriasis	0.000343	0.00249	CrCrCtD
Betamethasone—Clobetasol propionate—Triamcinolone—psoriasis	0.000343	0.00249	CrCrCtD
Betamethasone—Paramethasone—Dexamethasone—psoriasis	0.000342	0.00249	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Prednisolone—psoriasis	0.000335	0.00243	CrCrCtD
Betamethasone—Alclometasone—Prednisolone—psoriasis	0.000335	0.00243	CrCrCtD
Betamethasone—Paramethasone—Triamcinolone—psoriasis	0.000334	0.00243	CrCrCtD
Betamethasone—Budesonide—Prednisone—psoriasis	0.000334	0.00243	CrCrCtD
Betamethasone—Amcinonide—Prednisone—psoriasis	0.000334	0.00243	CrCrCtD
Betamethasone—Desoximetasone—Dexamethasone—psoriasis	0.000334	0.00243	CrCrCtD
Betamethasone—Methylprednisolone—Hydrocortisone—psoriasis	0.000328	0.00238	CrCrCtD
Betamethasone—Desoximetasone—Triamcinolone—psoriasis	0.000326	0.00237	CrCrCtD
Betamethasone—Budesonide—Prednisolone—psoriasis	0.000326	0.00237	CrCrCtD
Betamethasone—Amcinonide—Prednisolone—psoriasis	0.000326	0.00237	CrCrCtD
Betamethasone—Fluoxymesterone—Prednisolone—psoriasis	0.000326	0.00237	CrCrCtD
Betamethasone—Fluorometholone—Dexamethasone—psoriasis	0.000326	0.00237	CrCrCtD
Betamethasone—Triamcinolone—Dexamethasone—psoriasis	0.000326	0.00237	CrCrCtD
Betamethasone—Mometasone—Dexamethasone—psoriasis	0.000326	0.00237	CrCrCtD
Betamethasone—Fluprednidene Acetate—Dexamethasone—psoriasis	0.000326	0.00237	CrCrCtD
Betamethasone—Loteprednol—Dexamethasone—psoriasis	0.000326	0.00237	CrCrCtD
Betamethasone—Flunisolide—Prednisone—psoriasis	0.000325	0.00236	CrCrCtD
Betamethasone—Fludrocortisone—Prednisone—psoriasis	0.000325	0.00236	CrCrCtD
Betamethasone—Clobetasol propionate—Prednisone—psoriasis	0.000325	0.00236	CrCrCtD
Betamethasone—Desonide—Prednisone—psoriasis	0.000325	0.00236	CrCrCtD
Betamethasone—Diflorasone—Prednisone—psoriasis	0.000325	0.00236	CrCrCtD
Betamethasone—Prednisolone—Hydrocortisone—psoriasis	0.000321	0.00233	CrCrCtD
Betamethasone—Rimexolone—Dexamethasone—psoriasis	0.000318	0.00231	CrCrCtD
Betamethasone—Fluorometholone—Triamcinolone—psoriasis	0.000318	0.00231	CrCrCtD
Betamethasone—Mometasone—Triamcinolone—psoriasis	0.000318	0.00231	CrCrCtD
Betamethasone—Fluprednidene Acetate—Triamcinolone—psoriasis	0.000318	0.00231	CrCrCtD
Betamethasone—Loteprednol—Triamcinolone—psoriasis	0.000318	0.00231	CrCrCtD
Betamethasone—Clobetasol propionate—Prednisolone—psoriasis	0.000318	0.00231	CrCrCtD
Betamethasone—Prednisone—Prednisolone—psoriasis	0.000318	0.00231	CrCrCtD
Betamethasone—Diflorasone—Prednisolone—psoriasis	0.000318	0.00231	CrCrCtD
Betamethasone—Fludrocortisone—Prednisolone—psoriasis	0.000318	0.00231	CrCrCtD
Betamethasone—Flunisolide—Prednisolone—psoriasis	0.000318	0.00231	CrCrCtD
Betamethasone—Desonide—Prednisolone—psoriasis	0.000318	0.00231	CrCrCtD
Betamethasone—Paramethasone—Prednisone—psoriasis	0.000317	0.00231	CrCrCtD
Betamethasone—Dexamethasone—Triamcinolone—psoriasis	0.000311	0.00226	CrCrCtD
Betamethasone—Rimexolone—Triamcinolone—psoriasis	0.000311	0.00226	CrCrCtD
Betamethasone—Paramethasone—Prednisolone—psoriasis	0.00031	0.00225	CrCrCtD
Betamethasone—Desoximetasone—Prednisone—psoriasis	0.00031	0.00225	CrCrCtD
Betamethasone—Methylprednisolone—Dexamethasone—psoriasis	0.000305	0.00221	CrCrCtD
Betamethasone—Triamcinolone—Prednisone—psoriasis	0.000302	0.0022	CrCrCtD
Betamethasone—Mometasone—Prednisone—psoriasis	0.000302	0.0022	CrCrCtD
Betamethasone—Fluprednidene Acetate—Prednisone—psoriasis	0.000302	0.0022	CrCrCtD
Betamethasone—Loteprednol—Prednisone—psoriasis	0.000302	0.0022	CrCrCtD
Betamethasone—Fluorometholone—Prednisone—psoriasis	0.000302	0.0022	CrCrCtD
Betamethasone—Desoximetasone—Prednisolone—psoriasis	0.000302	0.0022	CrCrCtD
Betamethasone—Prednisolone—Dexamethasone—psoriasis	0.000298	0.00217	CrCrCtD
Betamethasone—Methylprednisolone—Triamcinolone—psoriasis	0.000298	0.00216	CrCrCtD
Betamethasone—Dexamethasone—Prednisone—psoriasis	0.000295	0.00215	CrCrCtD
Betamethasone—Rimexolone—Prednisone—psoriasis	0.000295	0.00215	CrCrCtD
Betamethasone—Fluorometholone—Prednisolone—psoriasis	0.000295	0.00214	CrCrCtD
Betamethasone—Triamcinolone—Prednisolone—psoriasis	0.000295	0.00214	CrCrCtD
Betamethasone—Mometasone—Prednisolone—psoriasis	0.000295	0.00214	CrCrCtD
Betamethasone—Fluprednidene Acetate—Prednisolone—psoriasis	0.000295	0.00214	CrCrCtD
Betamethasone—Loteprednol—Prednisolone—psoriasis	0.000295	0.00214	CrCrCtD
Betamethasone—Prednisolone—Triamcinolone—psoriasis	0.000291	0.00212	CrCrCtD
Betamethasone—Dexamethasone—Prednisolone—psoriasis	0.000288	0.00209	CrCrCtD
Betamethasone—Rimexolone—Prednisolone—psoriasis	0.000288	0.00209	CrCrCtD
Betamethasone—Hydrocortisone—Dexamethasone—psoriasis	0.000286	0.00208	CrCrCtD
Betamethasone—Methylprednisolone—Prednisone—psoriasis	0.000282	0.00205	CrCrCtD
Betamethasone—Hydrocortisone—Triamcinolone—psoriasis	0.00028	0.00203	CrCrCtD
Betamethasone—Prednisolone—Prednisone—psoriasis	0.000276	0.00201	CrCrCtD
Betamethasone—Methylprednisolone—Prednisolone—psoriasis	0.000276	0.002	CrCrCtD
Betamethasone—CYP3A4—Dexamethasone—psoriasis	0.000266	0.00253	CbGbCtD
Betamethasone—Hydrocortisone—Prednisone—psoriasis	0.000265	0.00193	CrCrCtD
Betamethasone—Hydrocortisone—Prednisolone—psoriasis	0.000259	0.00188	CrCrCtD
Betamethasone—NR3C2—ACE Inhibitor Pathway—ACE—psoriasis	0.000221	0.058	CbGpPWpGaD
Betamethasone—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	8.72e-05	0.173	CbGdCrCtD
Betamethasone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	8.58e-05	0.0225	CbGpPWpGaD
Betamethasone—CYP19A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	8.47e-05	0.0222	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL22—psoriasis	7.85e-05	0.0206	CbGpPWpGaD
Betamethasone—NR3C2—Nuclear Receptor transcription pathway—VDR—psoriasis	7.14e-05	0.0187	CbGpPWpGaD
Betamethasone—PTGS2—Fluocinonide—Beclomethasone—psoriasis	6.98e-05	0.139	CbGdCrCtD
Betamethasone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	6.95e-05	0.0182	CbGpPWpGaD
Betamethasone—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	6.78e-05	0.135	CbGdCrCtD
Betamethasone—PGR—Ovarian Infertility Genes—VDR—psoriasis	6.31e-05	0.0165	CbGpPWpGaD
Betamethasone—CYP3A4—Xenobiotics—CYP2S1—psoriasis	6.03e-05	0.0158	CbGpPWpGaD
Betamethasone—PGR—Nuclear Receptors—VDR—psoriasis	5.5e-05	0.0144	CbGpPWpGaD
Betamethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	5.44e-05	0.0142	CbGpPWpGaD
Betamethasone—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	5.26e-05	0.104	CbGdCrCtD
Betamethasone—NR3C2—Nuclear Receptor transcription pathway—PPARG—psoriasis	4.97e-05	0.013	CbGpPWpGaD
Betamethasone—PGR—Nuclear Receptor transcription pathway—VDR—psoriasis	4.35e-05	0.0114	CbGpPWpGaD
Betamethasone—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	4.21e-05	0.0837	CbGdCrCtD
Betamethasone—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	4.21e-05	0.0837	CbGdCrCtD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—REL—psoriasis	4.14e-05	0.0108	CbGpPWpGaD
Betamethasone—CYP19A1—Ovarian Infertility Genes—VDR—psoriasis	4.14e-05	0.0108	CbGpPWpGaD
Betamethasone—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	4.09e-05	0.0813	CbGdCrCtD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—CARM1—psoriasis	4.08e-05	0.0107	CbGpPWpGaD
Betamethasone—NR3C1—Circadian Clock—CARM1—psoriasis	3.96e-05	0.0104	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—psoriasis	3.94e-05	0.0103	CbGpPWpGaD
Betamethasone—PGR—Nuclear Receptors—PPARG—psoriasis	3.83e-05	0.01	CbGpPWpGaD
Betamethasone—CYP19A1—Biological oxidations—CYP2S1—psoriasis	3.69e-05	0.00968	CbGpPWpGaD
Betamethasone—CYP19A1—Metapathway biotransformation—CYP2S1—psoriasis	3.64e-05	0.00954	CbGpPWpGaD
Betamethasone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	3.59e-05	0.0094	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—psoriasis	3.43e-05	0.00899	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—CRP—psoriasis	3.43e-05	0.00899	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	3.42e-05	0.00895	CbGpPWpGaD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—JUN—psoriasis	3.34e-05	0.00876	CbGpPWpGaD
Betamethasone—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	3.25e-05	0.00851	CbGpPWpGaD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—NFKB1—psoriasis	3.22e-05	0.00843	CbGpPWpGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	3.22e-05	0.00843	CbGpPWpGaD
Betamethasone—CYP19A1—Tryptophan metabolism—CAT—psoriasis	3.19e-05	0.00835	CbGpPWpGaD
Betamethasone—PTGS2—Fluocinonide—Dexamethasone—psoriasis	3.18e-05	0.0632	CbGdCrCtD
Betamethasone—NR3C1—Nuclear Receptors—VDR—psoriasis	3.18e-05	0.00833	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—TARS—psoriasis	3.16e-05	0.00827	CbGpPWpGaD
Betamethasone—PGR—Cellular roles of Anthrax toxin—TNF—psoriasis	3.15e-05	0.00826	CbGpPWpGaD
Betamethasone—PTGS2—Fluocinonide—Triamcinolone—psoriasis	3.11e-05	0.0617	CbGdCrCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	3.11e-05	0.00814	CbGpPWpGaD
Betamethasone—PGR—Nuclear Receptor transcription pathway—PPARG—psoriasis	3.03e-05	0.00794	CbGpPWpGaD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—psoriasis	2.83e-05	0.00741	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL13—psoriasis	2.67e-05	0.007	CbGpPWpGaD
Betamethasone—NR3C1—Nuclear Receptor transcription pathway—VDR—psoriasis	2.51e-05	0.00658	CbGpPWpGaD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	2.5e-05	0.00656	CbGpPWpGaD
Betamethasone—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	2.47e-05	0.00647	CbGpPWpGaD
Betamethasone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	2.38e-05	0.00623	CbGpPWpGaD
Betamethasone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	2.29e-05	0.006	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—CXCL8—psoriasis	2.23e-05	0.00584	CbGpPWpGaD
Betamethasone—NR3C1—Nuclear Receptors—PPARG—psoriasis	2.22e-05	0.0058	CbGpPWpGaD
Betamethasone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	2.08e-05	0.00545	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—CARM1—psoriasis	2.06e-05	0.00541	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—NDUFA5—psoriasis	2.03e-05	0.00533	CbGpPWpGaD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.03e-05	0.00532	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—RUNX3—psoriasis	2.02e-05	0.0053	CbGpPWpGaD
Betamethasone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	2e-05	0.00524	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	1.93e-05	0.00505	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—TARS—psoriasis	1.92e-05	0.00504	CbGpPWpGaD
Betamethasone—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	1.92e-05	0.0381	CbGdCrCtD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	1.92e-05	0.00503	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.9e-05	0.00497	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL10—psoriasis	1.9e-05	0.00497	CbGpPWpGaD
Betamethasone—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	1.88e-05	0.0373	CbGdCrCtD
Betamethasone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.87e-05	0.00489	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL4—psoriasis	1.84e-05	0.00483	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—psoriasis	1.83e-05	0.00479	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—psoriasis	1.82e-05	0.00477	CbGpPWpGaD
Betamethasone—PTGS2—S1P1 pathway—VEGFA—psoriasis	1.81e-05	0.00475	CbGpPWpGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	1.79e-05	0.00469	CbGpPWpGaD
Betamethasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—psoriasis	1.75e-05	0.00459	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	1.73e-05	0.00454	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CYP2S1—psoriasis	1.73e-05	0.00453	CbGpPWpGaD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—psoriasis	1.71e-05	0.00448	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	1.69e-05	0.00442	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—HLA-A—psoriasis	1.67e-05	0.00438	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL4—psoriasis	1.63e-05	0.00426	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL13—psoriasis	1.6e-05	0.00418	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—TNF—psoriasis	1.55e-05	0.00407	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-C—psoriasis	1.49e-05	0.0039	CbGpPWpGaD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—psoriasis	1.48e-05	0.00387	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL13—psoriasis	1.48e-05	0.00387	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—psoriasis	1.47e-05	0.00385	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	1.44e-05	0.00378	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL17A—psoriasis	1.36e-05	0.00356	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—psoriasis	1.35e-05	0.00353	CbGpPWpGaD
Betamethasone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.3e-05	0.00341	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	1.29e-05	0.00338	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—SOCS1—psoriasis	1.29e-05	0.00338	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	1.27e-05	0.00333	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—CAT—psoriasis	1.27e-05	0.00332	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL12B—psoriasis	1.26e-05	0.00331	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—CARM1—psoriasis	1.26e-05	0.00329	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—IL6—psoriasis	1.25e-05	0.00328	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-E—psoriasis	1.23e-05	0.00323	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—VDR—psoriasis	1.23e-05	0.00323	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—JUN—psoriasis	1.2e-05	0.00316	CbGpPWpGaD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.15e-05	0.00301	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IFNG—psoriasis	1.12e-05	0.00292	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—TARS—psoriasis	1.11e-05	0.00291	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—TYK2—psoriasis	1.11e-05	0.0029	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—psoriasis	1.11e-05	0.0029	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP2S1—psoriasis	1.08e-05	0.00282	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	1.06e-05	0.00279	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—CXCL8—psoriasis	1.04e-05	0.00272	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—psoriasis	1.03e-05	0.00269	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	1.02e-05	0.00268	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—CRP—psoriasis	1.01e-05	0.00264	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL10—psoriasis	9.99e-06	0.00262	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—CARM1—psoriasis	9.94e-06	0.0026	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	9.84e-06	0.00258	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	9.83e-06	0.00257	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—JUN—psoriasis	9.64e-06	0.00253	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	9.56e-06	0.00251	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—LEP—psoriasis	9.51e-06	0.00249	CbGpPWpGaD
Betamethasone—CYP3A4—Tryptophan metabolism—CAT—psoriasis	9.3e-06	0.00244	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—ICAM1—psoriasis	9.25e-06	0.00242	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL10—psoriasis	9.25e-06	0.00242	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL4—psoriasis	9.21e-06	0.00241	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	9.14e-06	0.00239	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.07e-06	0.00238	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL4—psoriasis	9e-06	0.00236	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	8.93e-06	0.00234	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HCAR2—psoriasis	8.91e-06	0.00233	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-B—psoriasis	8.8e-06	0.0023	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	8.79e-06	0.0023	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—PPARG—psoriasis	8.59e-06	0.00225	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	8.58e-06	0.00225	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—JUN—psoriasis	8.49e-06	0.00223	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CARM1—psoriasis	8.45e-06	0.00221	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	8.4e-06	0.0022	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—PPARG—psoriasis	8.28e-06	0.00217	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	8.19e-06	0.00215	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	8.18e-06	0.00214	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-A—psoriasis	8.15e-06	0.00214	CbGpPWpGaD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.02e-06	0.0021	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.9e-06	0.00207	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—LEP—psoriasis	7.79e-06	0.00204	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TAGAP—psoriasis	7.73e-06	0.00202	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriasis	7.65e-06	0.00201	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—VDR—psoriasis	7.51e-06	0.00197	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	7.45e-06	0.00195	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NDUFA5—psoriasis	7.43e-06	0.00195	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—ICAM1—psoriasis	7.31e-06	0.00192	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—CARM1—psoriasis	7.27e-06	0.0019	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—NOS2—psoriasis	7.26e-06	0.0019	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriasis	7.16e-06	0.00188	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CD4—psoriasis	7.06e-06	0.00185	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IFNG—psoriasis	7.04e-06	0.00184	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.93e-06	0.00181	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—psoriasis	6.36e-06	0.00167	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP2S1—psoriasis	6.32e-06	0.00165	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—CARM1—psoriasis	6.05e-06	0.00159	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—VDR—psoriasis	5.93e-06	0.00155	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	5.91e-06	0.00155	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	5.88e-06	0.00154	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—NFKB1—psoriasis	5.86e-06	0.00153	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL6—psoriasis	5.83e-06	0.00153	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	5.69e-06	0.00149	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	5.61e-06	0.00147	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IFNG—psoriasis	5.57e-06	0.00146	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	5.46e-06	0.00143	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IFNG—psoriasis	5.44e-06	0.00142	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	5.43e-06	0.00142	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—IL6—psoriasis	5.42e-06	0.00142	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—PPARG—psoriasis	5.23e-06	0.00137	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CAT—psoriasis	5.2e-06	0.00136	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	5.18e-06	0.00136	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	5.16e-06	0.00135	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	5.13e-06	0.00134	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—STAT3—psoriasis	5.08e-06	0.00133	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	5.08e-06	0.00133	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CXCL8—psoriasis	5.06e-06	0.00132	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NDUFA5—psoriasis	4.96e-06	0.0013	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	4.94e-06	0.00129	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	4.89e-06	0.00128	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	4.74e-06	0.00124	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.63e-06	0.00121	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCL20—psoriasis	4.63e-06	0.00121	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	4.56e-06	0.00119	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.44e-06	0.00116	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TNF—psoriasis	4.4e-06	0.00115	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—VDR—psoriasis	4.34e-06	0.00114	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP2S1—psoriasis	4.22e-06	0.00111	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	4.17e-06	0.00109	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—PPARG—psoriasis	4.14e-06	0.00108	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—VEGFA—psoriasis	4.11e-06	0.00108	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—APOE—psoriasis	4.04e-06	0.00106	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	3.9e-06	0.00102	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	3.87e-06	8.79e-05	CcSEcCtD
Betamethasone—Anaphylactic shock—Hydrocortisone—psoriasis	3.87e-06	8.79e-05	CcSEcCtD
Betamethasone—Oedema—Hydrocortisone—psoriasis	3.87e-06	8.79e-05	CcSEcCtD
Betamethasone—Convulsion—Triamcinolone—psoriasis	3.87e-06	8.79e-05	CcSEcCtD
Betamethasone—Tachycardia—Prednisolone—psoriasis	3.87e-06	8.78e-05	CcSEcCtD
Betamethasone—Asthenia—Mycophenolic acid—psoriasis	3.86e-06	8.77e-05	CcSEcCtD
Betamethasone—Hypertension—Triamcinolone—psoriasis	3.85e-06	8.76e-05	CcSEcCtD
Betamethasone—Infection—Hydrocortisone—psoriasis	3.84e-06	8.73e-05	CcSEcCtD
Betamethasone—Insomnia—Mycophenolate mofetil—psoriasis	3.84e-06	8.73e-05	CcSEcCtD
Betamethasone—Dyspepsia—Cyclosporine—psoriasis	3.83e-06	8.71e-05	CcSEcCtD
Betamethasone—Hyperhidrosis—Prednisolone—psoriasis	3.83e-06	8.7e-05	CcSEcCtD
Betamethasone—Nausea—Hydroxyurea—psoriasis	3.82e-06	8.67e-05	CcSEcCtD
Betamethasone—Paraesthesia—Mycophenolate mofetil—psoriasis	3.81e-06	8.66e-05	CcSEcCtD
Betamethasone—Pruritus—Mycophenolic acid—psoriasis	3.81e-06	8.65e-05	CcSEcCtD
Betamethasone—Shock—Hydrocortisone—psoriasis	3.81e-06	8.65e-05	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	3.8e-06	0.000996	CbGpPWpGaD
Betamethasone—Myalgia—Triamcinolone—psoriasis	3.8e-06	8.63e-05	CcSEcCtD
Betamethasone—Nervous system disorder—Hydrocortisone—psoriasis	3.79e-06	8.62e-05	CcSEcCtD
Betamethasone—Eye disorder—Prednisone—psoriasis	3.79e-06	8.6e-05	CcSEcCtD
Betamethasone—Decreased appetite—Cyclosporine—psoriasis	3.78e-06	8.6e-05	CcSEcCtD
Betamethasone—Tachycardia—Hydrocortisone—psoriasis	3.78e-06	8.58e-05	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Cyclosporine—psoriasis	3.76e-06	8.54e-05	CcSEcCtD
Betamethasone—Ill-defined disorder—Dexamethasone—psoriasis	3.76e-06	8.54e-05	CcSEcCtD
Betamethasone—Discomfort—Triamcinolone—psoriasis	3.76e-06	8.53e-05	CcSEcCtD
Betamethasone—Fatigue—Cyclosporine—psoriasis	3.75e-06	8.53e-05	CcSEcCtD
Betamethasone—Hyperhidrosis—Hydrocortisone—psoriasis	3.74e-06	8.5e-05	CcSEcCtD
Betamethasone—Dyspepsia—Mycophenolate mofetil—psoriasis	3.74e-06	8.49e-05	CcSEcCtD
Betamethasone—Pain—Cyclosporine—psoriasis	3.72e-06	8.46e-05	CcSEcCtD
Betamethasone—Angioedema—Dexamethasone—psoriasis	3.7e-06	8.41e-05	CcSEcCtD
Betamethasone—Decreased appetite—Mycophenolate mofetil—psoriasis	3.69e-06	8.39e-05	CcSEcCtD
Betamethasone—Anorexia—Hydrocortisone—psoriasis	3.69e-06	8.38e-05	CcSEcCtD
Betamethasone—Diarrhoea—Mycophenolic acid—psoriasis	3.68e-06	8.37e-05	CcSEcCtD
Betamethasone—Angiopathy—Prednisone—psoriasis	3.68e-06	8.35e-05	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	3.68e-06	0.000963	CbGpPWpGaD
Betamethasone—Conjunctivitis—Methotrexate—psoriasis	3.67e-06	8.33e-05	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	3.67e-06	8.33e-05	CcSEcCtD
Betamethasone—Malaise—Dexamethasone—psoriasis	3.65e-06	8.3e-05	CcSEcCtD
Betamethasone—Oedema—Triamcinolone—psoriasis	3.64e-06	8.28e-05	CcSEcCtD
Betamethasone—Anaphylactic shock—Triamcinolone—psoriasis	3.64e-06	8.28e-05	CcSEcCtD
Betamethasone—Vertigo—Dexamethasone—psoriasis	3.64e-06	8.27e-05	CcSEcCtD
Betamethasone—Syncope—Dexamethasone—psoriasis	3.63e-06	8.25e-05	CcSEcCtD
Betamethasone—Pain—Mycophenolate mofetil—psoriasis	3.63e-06	8.25e-05	CcSEcCtD
Betamethasone—Arrhythmia—Prednisone—psoriasis	3.62e-06	8.22e-05	CcSEcCtD
Betamethasone—Infection—Triamcinolone—psoriasis	3.62e-06	8.22e-05	CcSEcCtD
Betamethasone—Hypotension—Hydrocortisone—psoriasis	3.62e-06	8.21e-05	CcSEcCtD
Betamethasone—PGR—Gene Expression—VDR—psoriasis	3.61e-06	0.000947	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—psoriasis	3.6e-06	0.000944	CbGpPWpGaD
Betamethasone—Feeling abnormal—Cyclosporine—psoriasis	3.59e-06	8.15e-05	CcSEcCtD
Betamethasone—Shock—Triamcinolone—psoriasis	3.58e-06	8.14e-05	CcSEcCtD
Betamethasone—Insomnia—Prednisolone—psoriasis	3.58e-06	8.14e-05	CcSEcCtD
Betamethasone—Alopecia—Prednisone—psoriasis	3.58e-06	8.14e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Cyclosporine—psoriasis	3.56e-06	8.09e-05	CcSEcCtD
Betamethasone—Loss of consciousness—Dexamethasone—psoriasis	3.56e-06	8.09e-05	CcSEcCtD
Betamethasone—Dizziness—Mycophenolic acid—psoriasis	3.56e-06	8.09e-05	CcSEcCtD
Betamethasone—Paraesthesia—Prednisolone—psoriasis	3.56e-06	8.08e-05	CcSEcCtD
Betamethasone—Tachycardia—Triamcinolone—psoriasis	3.56e-06	8.08e-05	CcSEcCtD
Betamethasone—NR3C1—Adipogenesis—IL6—psoriasis	3.55e-06	0.00093	CbGpPWpGaD
Betamethasone—Erythema—Prednisone—psoriasis	3.53e-06	8.01e-05	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Hydrocortisone—psoriasis	3.53e-06	8.01e-05	CcSEcCtD
Betamethasone—Hyperhidrosis—Triamcinolone—psoriasis	3.52e-06	8e-05	CcSEcCtD
Betamethasone—ABCB1—Allograft Rejection—TNF—psoriasis	3.52e-06	0.000922	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NDUFA5—psoriasis	3.52e-06	0.000922	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PPARG—psoriasis	3.52e-06	0.000921	CbGpPWpGaD
Betamethasone—Convulsion—Dexamethasone—psoriasis	3.51e-06	7.97e-05	CcSEcCtD
Betamethasone—Feeling abnormal—Mycophenolate mofetil—psoriasis	3.5e-06	7.95e-05	CcSEcCtD
Betamethasone—Insomnia—Hydrocortisone—psoriasis	3.5e-06	7.95e-05	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.5e-06	0.000917	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CARM1—psoriasis	3.5e-06	0.000916	CbGpPWpGaD
Betamethasone—Hypertension—Dexamethasone—psoriasis	3.5e-06	7.95e-05	CcSEcCtD
Betamethasone—Paraesthesia—Hydrocortisone—psoriasis	3.47e-06	7.89e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	3.47e-06	7.89e-05	CcSEcCtD
Betamethasone—Urticaria—Cyclosporine—psoriasis	3.46e-06	7.86e-05	CcSEcCtD
Betamethasone—Myalgia—Dexamethasone—psoriasis	3.45e-06	7.83e-05	CcSEcCtD
Betamethasone—Body temperature increased—Cyclosporine—psoriasis	3.44e-06	7.82e-05	CcSEcCtD
Betamethasone—Abdominal pain—Cyclosporine—psoriasis	3.44e-06	7.82e-05	CcSEcCtD
Betamethasone—Anxiety—Dexamethasone—psoriasis	3.44e-06	7.81e-05	CcSEcCtD
Betamethasone—Vomiting—Mycophenolic acid—psoriasis	3.42e-06	7.77e-05	CcSEcCtD
Betamethasone—Discomfort—Dexamethasone—psoriasis	3.41e-06	7.74e-05	CcSEcCtD
Betamethasone—Dyspepsia—Hydrocortisone—psoriasis	3.41e-06	7.74e-05	CcSEcCtD
Betamethasone—Haemoglobin—Methotrexate—psoriasis	3.4e-06	7.73e-05	CcSEcCtD
Betamethasone—Rash—Mycophenolic acid—psoriasis	3.39e-06	7.71e-05	CcSEcCtD
Betamethasone—Dermatitis—Mycophenolic acid—psoriasis	3.39e-06	7.7e-05	CcSEcCtD
Betamethasone—Pain—Prednisolone—psoriasis	3.39e-06	7.7e-05	CcSEcCtD
Betamethasone—Haemorrhage—Methotrexate—psoriasis	3.39e-06	7.69e-05	CcSEcCtD
Betamethasone—Urticaria—Mycophenolate mofetil—psoriasis	3.37e-06	7.67e-05	CcSEcCtD
Betamethasone—Headache—Mycophenolic acid—psoriasis	3.37e-06	7.66e-05	CcSEcCtD
Betamethasone—Decreased appetite—Hydrocortisone—psoriasis	3.36e-06	7.64e-05	CcSEcCtD
Betamethasone—Body temperature increased—Mycophenolate mofetil—psoriasis	3.36e-06	7.63e-05	CcSEcCtD
Betamethasone—Abdominal pain—Mycophenolate mofetil—psoriasis	3.36e-06	7.63e-05	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Hydrocortisone—psoriasis	3.34e-06	7.59e-05	CcSEcCtD
Betamethasone—Fatigue—Hydrocortisone—psoriasis	3.34e-06	7.58e-05	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Triamcinolone—psoriasis	3.32e-06	7.54e-05	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.31e-06	0.000867	CbGpPWpGaD
Betamethasone—Pain—Hydrocortisone—psoriasis	3.31e-06	7.52e-05	CcSEcCtD
Betamethasone—Oedema—Dexamethasone—psoriasis	3.31e-06	7.51e-05	CcSEcCtD
Betamethasone—Anaphylactic shock—Dexamethasone—psoriasis	3.31e-06	7.51e-05	CcSEcCtD
Betamethasone—Insomnia—Triamcinolone—psoriasis	3.3e-06	7.49e-05	CcSEcCtD
Betamethasone—Infection—Dexamethasone—psoriasis	3.28e-06	7.46e-05	CcSEcCtD
Betamethasone—Ill-defined disorder—Prednisone—psoriasis	3.27e-06	7.44e-05	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.27e-06	0.000857	CbGpPWpGaD
Betamethasone—Paraesthesia—Triamcinolone—psoriasis	3.27e-06	7.43e-05	CcSEcCtD
Betamethasone—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	3.27e-06	0.000857	CbGpPWpGaD
Betamethasone—Feeling abnormal—Prednisolone—psoriasis	3.26e-06	7.42e-05	CcSEcCtD
Betamethasone—Visual impairment—Methotrexate—psoriasis	3.26e-06	7.41e-05	CcSEcCtD
Betamethasone—Shock—Dexamethasone—psoriasis	3.25e-06	7.39e-05	CcSEcCtD
Betamethasone—Nervous system disorder—Dexamethasone—psoriasis	3.24e-06	7.37e-05	CcSEcCtD
Betamethasone—Thrombocytopenia—Dexamethasone—psoriasis	3.24e-06	7.35e-05	CcSEcCtD
Betamethasone—Tachycardia—Dexamethasone—psoriasis	3.23e-06	7.33e-05	CcSEcCtD
Betamethasone—Angioedema—Prednisone—psoriasis	3.22e-06	7.32e-05	CcSEcCtD
Betamethasone—Dyspepsia—Triamcinolone—psoriasis	3.21e-06	7.29e-05	CcSEcCtD
Betamethasone—Nausea—Mycophenolic acid—psoriasis	3.2e-06	7.26e-05	CcSEcCtD
Betamethasone—Hyperhidrosis—Dexamethasone—psoriasis	3.2e-06	7.26e-05	CcSEcCtD
Betamethasone—Feeling abnormal—Hydrocortisone—psoriasis	3.19e-06	7.24e-05	CcSEcCtD
Betamethasone—Malaise—Prednisone—psoriasis	3.18e-06	7.23e-05	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—psoriasis	3.18e-06	0.000832	CbGpPWpGaD
Betamethasone—Vertigo—Prednisone—psoriasis	3.17e-06	7.2e-05	CcSEcCtD
Betamethasone—Eye disorder—Methotrexate—psoriasis	3.16e-06	7.19e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Hydrocortisone—psoriasis	3.16e-06	7.19e-05	CcSEcCtD
Betamethasone—Syncope—Prednisone—psoriasis	3.16e-06	7.19e-05	CcSEcCtD
Betamethasone—Anorexia—Dexamethasone—psoriasis	3.15e-06	7.16e-05	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.15e-06	0.000825	CbGpPWpGaD
Betamethasone—Urticaria—Prednisolone—psoriasis	3.15e-06	7.15e-05	CcSEcCtD
Betamethasone—Fatigue—Triamcinolone—psoriasis	3.14e-06	7.14e-05	CcSEcCtD
Betamethasone—Asthenia—Cyclosporine—psoriasis	3.12e-06	7.1e-05	CcSEcCtD
Betamethasone—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	3.12e-06	0.000817	CbGpPWpGaD
Betamethasone—Pain—Triamcinolone—psoriasis	3.12e-06	7.08e-05	CcSEcCtD
Betamethasone—Loss of consciousness—Prednisone—psoriasis	3.1e-06	7.04e-05	CcSEcCtD
Betamethasone—Hypotension—Dexamethasone—psoriasis	3.09e-06	7.02e-05	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—CARM1—psoriasis	3.09e-06	0.000808	CbGpPWpGaD
Betamethasone—Pruritus—Cyclosporine—psoriasis	3.08e-06	7e-05	CcSEcCtD
Betamethasone—Urticaria—Hydrocortisone—psoriasis	3.07e-06	6.98e-05	CcSEcCtD
Betamethasone—Angiopathy—Methotrexate—psoriasis	3.07e-06	6.98e-05	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	3.07e-06	0.000804	CbGpPWpGaD
Betamethasone—Body temperature increased—Hydrocortisone—psoriasis	3.06e-06	6.95e-05	CcSEcCtD
Betamethasone—Abdominal pain—Hydrocortisone—psoriasis	3.06e-06	6.95e-05	CcSEcCtD
Betamethasone—Convulsion—Prednisone—psoriasis	3.06e-06	6.94e-05	CcSEcCtD
Betamethasone—Asthenia—Mycophenolate mofetil—psoriasis	3.05e-06	6.92e-05	CcSEcCtD
Betamethasone—Hypertension—Prednisone—psoriasis	3.05e-06	6.92e-05	CcSEcCtD
Betamethasone—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	3.02e-06	0.000792	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.01e-06	6.84e-05	CcSEcCtD
Betamethasone—Pruritus—Mycophenolate mofetil—psoriasis	3e-06	6.83e-05	CcSEcCtD
Betamethasone—Myalgia—Prednisone—psoriasis	3e-06	6.82e-05	CcSEcCtD
Betamethasone—Feeling abnormal—Triamcinolone—psoriasis	3e-06	6.82e-05	CcSEcCtD
Betamethasone—Anxiety—Prednisone—psoriasis	2.99e-06	6.8e-05	CcSEcCtD
Betamethasone—Alopecia—Methotrexate—psoriasis	2.99e-06	6.8e-05	CcSEcCtD
Betamethasone—ABCB1—Metabolism—CYP2S1—psoriasis	2.99e-06	0.000784	CbGpPWpGaD
Betamethasone—Insomnia—Dexamethasone—psoriasis	2.99e-06	6.79e-05	CcSEcCtD
Betamethasone—Diarrhoea—Cyclosporine—psoriasis	2.98e-06	6.77e-05	CcSEcCtD
Betamethasone—Paraesthesia—Dexamethasone—psoriasis	2.97e-06	6.74e-05	CcSEcCtD
Betamethasone—Discomfort—Prednisone—psoriasis	2.97e-06	6.74e-05	CcSEcCtD
Betamethasone—Erythema—Methotrexate—psoriasis	2.95e-06	6.7e-05	CcSEcCtD
Betamethasone—Dyspepsia—Dexamethasone—psoriasis	2.91e-06	6.61e-05	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—IL6—psoriasis	2.91e-06	0.000762	CbGpPWpGaD
Betamethasone—Diarrhoea—Mycophenolate mofetil—psoriasis	2.91e-06	6.6e-05	CcSEcCtD
Betamethasone—Urticaria—Triamcinolone—psoriasis	2.89e-06	6.58e-05	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.88e-06	0.000755	CbGpPWpGaD
Betamethasone—Body temperature increased—Triamcinolone—psoriasis	2.88e-06	6.54e-05	CcSEcCtD
Betamethasone—Dizziness—Cyclosporine—psoriasis	2.88e-06	6.54e-05	CcSEcCtD
Betamethasone—Anaphylactic shock—Prednisone—psoriasis	2.88e-06	6.54e-05	CcSEcCtD
Betamethasone—Oedema—Prednisone—psoriasis	2.88e-06	6.54e-05	CcSEcCtD
Betamethasone—Decreased appetite—Dexamethasone—psoriasis	2.87e-06	6.53e-05	CcSEcCtD
Betamethasone—Infection—Prednisone—psoriasis	2.86e-06	6.5e-05	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.86e-06	0.000749	CbGpPWpGaD
Betamethasone—Gastrointestinal disorder—Dexamethasone—psoriasis	2.85e-06	6.48e-05	CcSEcCtD
Betamethasone—Fatigue—Dexamethasone—psoriasis	2.85e-06	6.48e-05	CcSEcCtD
Betamethasone—Shock—Prednisone—psoriasis	2.83e-06	6.44e-05	CcSEcCtD
Betamethasone—Pain—Dexamethasone—psoriasis	2.83e-06	6.42e-05	CcSEcCtD
Betamethasone—Nervous system disorder—Prednisone—psoriasis	2.82e-06	6.41e-05	CcSEcCtD
Betamethasone—Tachycardia—Prednisone—psoriasis	2.81e-06	6.38e-05	CcSEcCtD
Betamethasone—Dizziness—Mycophenolate mofetil—psoriasis	2.81e-06	6.38e-05	CcSEcCtD
Betamethasone—Hyperhidrosis—Prednisone—psoriasis	2.78e-06	6.32e-05	CcSEcCtD
Betamethasone—Asthenia—Hydrocortisone—psoriasis	2.78e-06	6.31e-05	CcSEcCtD
Betamethasone—Vomiting—Cyclosporine—psoriasis	2.77e-06	6.29e-05	CcSEcCtD
Betamethasone—Rash—Cyclosporine—psoriasis	2.75e-06	6.24e-05	CcSEcCtD
Betamethasone—Anorexia—Prednisone—psoriasis	2.74e-06	6.23e-05	CcSEcCtD
Betamethasone—Dermatitis—Cyclosporine—psoriasis	2.74e-06	6.23e-05	CcSEcCtD
Betamethasone—Pruritus—Hydrocortisone—psoriasis	2.74e-06	6.22e-05	CcSEcCtD
Betamethasone—Ill-defined disorder—Methotrexate—psoriasis	2.74e-06	6.21e-05	CcSEcCtD
Betamethasone—Headache—Cyclosporine—psoriasis	2.73e-06	6.2e-05	CcSEcCtD
Betamethasone—Feeling abnormal—Dexamethasone—psoriasis	2.72e-06	6.19e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Dexamethasone—psoriasis	2.7e-06	6.14e-05	CcSEcCtD
Betamethasone—Vomiting—Mycophenolate mofetil—psoriasis	2.7e-06	6.14e-05	CcSEcCtD
Betamethasone—Rash—Mycophenolate mofetil—psoriasis	2.68e-06	6.08e-05	CcSEcCtD
Betamethasone—Dermatitis—Mycophenolate mofetil—psoriasis	2.68e-06	6.08e-05	CcSEcCtD
Betamethasone—Headache—Mycophenolate mofetil—psoriasis	2.66e-06	6.05e-05	CcSEcCtD
Betamethasone—Malaise—Methotrexate—psoriasis	2.66e-06	6.04e-05	CcSEcCtD
Betamethasone—Vertigo—Methotrexate—psoriasis	2.65e-06	6.02e-05	CcSEcCtD
Betamethasone—Diarrhoea—Hydrocortisone—psoriasis	2.65e-06	6.01e-05	CcSEcCtD
Betamethasone—Urticaria—Dexamethasone—psoriasis	2.63e-06	5.97e-05	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Prednisone—psoriasis	2.62e-06	5.96e-05	CcSEcCtD
Betamethasone—Dizziness—Prednisolone—psoriasis	2.62e-06	5.95e-05	CcSEcCtD
Betamethasone—Asthenia—Triamcinolone—psoriasis	2.61e-06	5.94e-05	CcSEcCtD
Betamethasone—Body temperature increased—Dexamethasone—psoriasis	2.61e-06	5.94e-05	CcSEcCtD
Betamethasone—Abdominal pain—Dexamethasone—psoriasis	2.61e-06	5.94e-05	CcSEcCtD
Betamethasone—Insomnia—Prednisone—psoriasis	2.6e-06	5.92e-05	CcSEcCtD
Betamethasone—Nausea—Cyclosporine—psoriasis	2.59e-06	5.88e-05	CcSEcCtD
Betamethasone—Paraesthesia—Prednisone—psoriasis	2.59e-06	5.87e-05	CcSEcCtD
Betamethasone—Pruritus—Triamcinolone—psoriasis	2.58e-06	5.86e-05	CcSEcCtD
Betamethasone—Dizziness—Hydrocortisone—psoriasis	2.56e-06	5.81e-05	CcSEcCtD
Betamethasone—Convulsion—Methotrexate—psoriasis	2.55e-06	5.8e-05	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—SOCS1—psoriasis	2.55e-06	0.000668	CbGpPWpGaD
Betamethasone—Dyspepsia—Prednisone—psoriasis	2.53e-06	5.76e-05	CcSEcCtD
Betamethasone—Nausea—Mycophenolate mofetil—psoriasis	2.52e-06	5.73e-05	CcSEcCtD
Betamethasone—PGR—Gene Expression—PPARG—psoriasis	2.52e-06	0.00066	CbGpPWpGaD
Betamethasone—Myalgia—Methotrexate—psoriasis	2.51e-06	5.7e-05	CcSEcCtD
Betamethasone—Decreased appetite—Prednisone—psoriasis	2.5e-06	5.69e-05	CcSEcCtD
Betamethasone—Rash—Prednisolone—psoriasis	2.5e-06	5.68e-05	CcSEcCtD
Betamethasone—Dermatitis—Prednisolone—psoriasis	2.5e-06	5.67e-05	CcSEcCtD
Betamethasone—Fatigue—Prednisone—psoriasis	2.48e-06	5.64e-05	CcSEcCtD
Betamethasone—Headache—Prednisolone—psoriasis	2.48e-06	5.64e-05	CcSEcCtD
Betamethasone—Discomfort—Methotrexate—psoriasis	2.48e-06	5.63e-05	CcSEcCtD
Betamethasone—Vomiting—Hydrocortisone—psoriasis	2.46e-06	5.59e-05	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.45e-06	0.000642	CbGpPWpGaD
Betamethasone—Rash—Hydrocortisone—psoriasis	2.44e-06	5.54e-05	CcSEcCtD
Betamethasone—Dermatitis—Hydrocortisone—psoriasis	2.44e-06	5.54e-05	CcSEcCtD
Betamethasone—Headache—Hydrocortisone—psoriasis	2.42e-06	5.51e-05	CcSEcCtD
Betamethasone—Dizziness—Triamcinolone—psoriasis	2.41e-06	5.47e-05	CcSEcCtD
Betamethasone—Anaphylactic shock—Methotrexate—psoriasis	2.41e-06	5.47e-05	CcSEcCtD
Betamethasone—Infection—Methotrexate—psoriasis	2.39e-06	5.43e-05	CcSEcCtD
Betamethasone—Feeling abnormal—Prednisone—psoriasis	2.37e-06	5.39e-05	CcSEcCtD
Betamethasone—Asthenia—Dexamethasone—psoriasis	2.37e-06	5.39e-05	CcSEcCtD
Betamethasone—Nervous system disorder—Methotrexate—psoriasis	2.36e-06	5.36e-05	CcSEcCtD
Betamethasone—Thrombocytopenia—Methotrexate—psoriasis	2.36e-06	5.35e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Prednisone—psoriasis	2.35e-06	5.35e-05	CcSEcCtD
Betamethasone—Nausea—Prednisolone—psoriasis	2.35e-06	5.35e-05	CcSEcCtD
Betamethasone—Pruritus—Dexamethasone—psoriasis	2.34e-06	5.31e-05	CcSEcCtD
Betamethasone—Hyperhidrosis—Methotrexate—psoriasis	2.33e-06	5.28e-05	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.32e-06	0.000608	CbGpPWpGaD
Betamethasone—Vomiting—Triamcinolone—psoriasis	2.32e-06	5.26e-05	CcSEcCtD
Betamethasone—Nausea—Hydrocortisone—psoriasis	2.3e-06	5.22e-05	CcSEcCtD
Betamethasone—Rash—Triamcinolone—psoriasis	2.3e-06	5.22e-05	CcSEcCtD
Betamethasone—Dermatitis—Triamcinolone—psoriasis	2.3e-06	5.21e-05	CcSEcCtD
Betamethasone—Anorexia—Methotrexate—psoriasis	2.29e-06	5.21e-05	CcSEcCtD
Betamethasone—Urticaria—Prednisone—psoriasis	2.29e-06	5.2e-05	CcSEcCtD
Betamethasone—Headache—Triamcinolone—psoriasis	2.28e-06	5.19e-05	CcSEcCtD
Betamethasone—Body temperature increased—Prednisone—psoriasis	2.28e-06	5.17e-05	CcSEcCtD
Betamethasone—Abdominal pain—Prednisone—psoriasis	2.28e-06	5.17e-05	CcSEcCtD
Betamethasone—Diarrhoea—Dexamethasone—psoriasis	2.26e-06	5.14e-05	CcSEcCtD
Betamethasone—Hypotension—Methotrexate—psoriasis	2.25e-06	5.11e-05	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.23e-06	0.000585	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.21e-06	0.00058	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Methotrexate—psoriasis	2.19e-06	4.98e-05	CcSEcCtD
Betamethasone—Dizziness—Dexamethasone—psoriasis	2.19e-06	4.97e-05	CcSEcCtD
Betamethasone—Insomnia—Methotrexate—psoriasis	2.18e-06	4.94e-05	CcSEcCtD
Betamethasone—CYP3A4—Metabolism—NDUFA5—psoriasis	2.17e-06	0.000568	CbGpPWpGaD
Betamethasone—Nausea—Triamcinolone—psoriasis	2.16e-06	4.92e-05	CcSEcCtD
Betamethasone—Paraesthesia—Methotrexate—psoriasis	2.16e-06	4.91e-05	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.16e-06	0.000566	CbGpPWpGaD
Betamethasone—Dyspepsia—Methotrexate—psoriasis	2.12e-06	4.81e-05	CcSEcCtD
Betamethasone—Vomiting—Dexamethasone—psoriasis	2.1e-06	4.78e-05	CcSEcCtD
Betamethasone—Decreased appetite—Methotrexate—psoriasis	2.09e-06	4.75e-05	CcSEcCtD
Betamethasone—NR3C1—Gene Expression—VDR—psoriasis	2.09e-06	0.000547	CbGpPWpGaD
Betamethasone—Rash—Dexamethasone—psoriasis	2.08e-06	4.74e-05	CcSEcCtD
Betamethasone—Dermatitis—Dexamethasone—psoriasis	2.08e-06	4.73e-05	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Methotrexate—psoriasis	2.08e-06	4.72e-05	CcSEcCtD
Betamethasone—Fatigue—Methotrexate—psoriasis	2.07e-06	4.71e-05	CcSEcCtD
Betamethasone—Headache—Dexamethasone—psoriasis	2.07e-06	4.71e-05	CcSEcCtD
Betamethasone—Asthenia—Prednisone—psoriasis	2.07e-06	4.69e-05	CcSEcCtD
Betamethasone—PTGS2—Metabolism—CARM1—psoriasis	2.06e-06	0.00054	CbGpPWpGaD
Betamethasone—Pain—Methotrexate—psoriasis	2.06e-06	4.67e-05	CcSEcCtD
Betamethasone—Pruritus—Prednisone—psoriasis	2.04e-06	4.63e-05	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.03e-06	0.000531	CbGpPWpGaD
Betamethasone—Feeling abnormal—Methotrexate—psoriasis	1.98e-06	4.5e-05	CcSEcCtD
Betamethasone—Diarrhoea—Prednisone—psoriasis	1.97e-06	4.48e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Methotrexate—psoriasis	1.97e-06	4.47e-05	CcSEcCtD
Betamethasone—Nausea—Dexamethasone—psoriasis	1.96e-06	4.46e-05	CcSEcCtD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.93e-06	0.000505	CbGpPWpGaD
Betamethasone—Urticaria—Methotrexate—psoriasis	1.91e-06	4.34e-05	CcSEcCtD
Betamethasone—Dizziness—Prednisone—psoriasis	1.9e-06	4.33e-05	CcSEcCtD
Betamethasone—Abdominal pain—Methotrexate—psoriasis	1.9e-06	4.32e-05	CcSEcCtD
Betamethasone—Body temperature increased—Methotrexate—psoriasis	1.9e-06	4.32e-05	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—CAT—psoriasis	1.9e-06	0.000497	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APOE—psoriasis	1.88e-06	0.000493	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LEP—psoriasis	1.88e-06	0.000493	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2S1—psoriasis	1.84e-06	0.000483	CbGpPWpGaD
Betamethasone—Vomiting—Prednisone—psoriasis	1.83e-06	4.16e-05	CcSEcCtD
Betamethasone—Rash—Prednisone—psoriasis	1.82e-06	4.12e-05	CcSEcCtD
Betamethasone—Dermatitis—Prednisone—psoriasis	1.81e-06	4.12e-05	CcSEcCtD
Betamethasone—Headache—Prednisone—psoriasis	1.8e-06	4.1e-05	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—NFKBIA—psoriasis	1.75e-06	0.000459	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.74e-06	0.000455	CbGpPWpGaD
Betamethasone—Asthenia—Methotrexate—psoriasis	1.73e-06	3.92e-05	CcSEcCtD
Betamethasone—Nausea—Prednisone—psoriasis	1.71e-06	3.89e-05	CcSEcCtD
Betamethasone—Pruritus—Methotrexate—psoriasis	1.7e-06	3.87e-05	CcSEcCtD
Betamethasone—Diarrhoea—Methotrexate—psoriasis	1.65e-06	3.74e-05	CcSEcCtD
Betamethasone—Dizziness—Methotrexate—psoriasis	1.59e-06	3.61e-05	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.53e-06	0.000401	CbGpPWpGaD
Betamethasone—Vomiting—Methotrexate—psoriasis	1.53e-06	3.48e-05	CcSEcCtD
Betamethasone—Rash—Methotrexate—psoriasis	1.52e-06	3.45e-05	CcSEcCtD
Betamethasone—Dermatitis—Methotrexate—psoriasis	1.52e-06	3.44e-05	CcSEcCtD
Betamethasone—Headache—Methotrexate—psoriasis	1.51e-06	3.42e-05	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—APOE—psoriasis	1.47e-06	0.000386	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CARM1—psoriasis	1.46e-06	0.000383	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARG—psoriasis	1.46e-06	0.000381	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TYK2—psoriasis	1.44e-06	0.000376	CbGpPWpGaD
Betamethasone—Nausea—Methotrexate—psoriasis	1.43e-06	3.25e-05	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—PPARG—psoriasis	1.28e-06	0.000336	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CAT—psoriasis	1.27e-06	0.000332	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HLA-A—psoriasis	1.26e-06	0.00033	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—psoriasis	1.25e-06	0.000327	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOE—psoriasis	1.18e-06	0.000308	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JUN—psoriasis	1.16e-06	0.000304	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NFKB1—psoriasis	1.12e-06	0.000293	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS2—psoriasis	1.1e-06	0.000287	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—psoriasis	1.02e-06	0.000266	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—psoriasis	1.01e-06	0.000263	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOE—psoriasis	9.85e-07	0.000258	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CARM1—psoriasis	9e-07	0.000236	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CAT—psoriasis	8.99e-07	0.000235	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TYK2—psoriasis	8.98e-07	0.000235	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARG—psoriasis	8.58e-07	0.000225	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD4—psoriasis	8.12e-07	0.000213	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—psoriasis	7.67e-07	0.000201	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—psoriasis	7.02e-07	0.000184	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOE—psoriasis	6.98e-07	0.000183	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—psoriasis	6.29e-07	0.000165	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARG—psoriasis	6.08e-07	0.000159	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CAT—psoriasis	5.54e-07	0.000145	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—psoriasis	4.39e-07	0.000115	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOE—psoriasis	4.3e-07	0.000113	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARG—psoriasis	3.75e-07	9.82e-05	CbGpPWpGaD
